The Novartis Patent Case: The Full Supreme Court Ruling

IP News

Home > IP News

The Novartis Patent Case: The Full Supreme Court Ruling


(These latest Intellectual Property (IP) news and events presented here,are prepared and compiled by us,the World Patent & Trademark Law Office (WPTO),for your reference and information)


    India’s Supreme Court ruled Monday againstSwiss drug-maker Novartis, which was seeking patent protection for a form of its popular cancer drug Gleevec.

    The highly-technical 112-page ruling delves into the intricate chemistry of drug compound formulation, the definition of efficacy, confusing changes to India’s patent laws since before Independence, the growth of the pharmaceutical industry in India and the need to protect India’s role as a cheap drug provider. On page two, the court notes:

    The Court was urged to strike a balance between the need to promote research and development in science and technology and to keep private monopoly (called an ‘aberration’ under our Constitutional scheme) at the minimum. Arguments were made about India’s obligation to faithfully comply with its commitments under international treaties and counter arguments were made to protect India’s status as “the pharmacy of the world.”

To continue reading, click here.


Privacy Statement
Our company is deeply committed to protecting the privacy and personal information of our users. In accordance with our website's privacy policy, we promise to safeguard user personal information from infringement. If you have any questions regarding our privacy policy, please feel free to contact us via email or phone. We are more than happy to assist you.